Pathogenesis of thyroid eye disease: review and update on molecular mechanisms

JJ Khong, AA McNab, PR Ebeling, JE Craig… - British Journal of …, 2016 - bjo.bmj.com
Orbital changes in thyroid orbitopathy (TO) result from de novo adipogenesis, hyaluronan
synthesis, interstitial oedema and enlargement of extraocular muscles. Cellular immunity …

Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy

Y Wang, TJ Smith - Investigative ophthalmology & visual …, 2014 - iovs.arvojournals.org
Graves' disease (GD) is a common autoimmune condition. At its core, stimulatory
autoantibodies are directed at the thyroid-stimulating hormone receptor (TSHR), resulting in …

Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity

RS Douglas, S Couch, ST Wester… - The Journal of …, 2024 - academic.oup.com
Context Early inflammatory thyroid eye disease (TED) can lead to symptomatic chronic
disease, including disabling proptosis. Teprotumumab, an insulin-like growth factor-1 …

Pituitary crosstalk with bone, adipose tissue and brain

M Zaidi, T Yuen, SM Kim - Nature Reviews Endocrinology, 2023 - nature.com
Traditional textbook physiology has ascribed unitary functions to hormones from the anterior
and posterior pituitary gland, mainly in the regulation of effector hormone secretion from …

Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment

JA Garrity, RS Bahn - American journal of ophthalmology, 2006 - Elsevier
PURPOSE: To review current concepts regarding the pathogenesis of Graves
ophthalmopathy (GO). We have presented this information in the context of potential target …

Role of adipose tissue as an inflammatory organ in human diseases

A Schaffler, U Muller-Ladner, J Scholmerich… - Endocrine …, 2006 - academic.oup.com
Reviews on the inflammatory role of adipose tissue outside the field of metabolism are rare.
There is increasing evidence provided by numerous basic research studies from nearly all …

The mysterious universe of the TSH receptor

IH Vieira, D Rodrigues, I Paiva - Frontiers in endocrinology, 2022 - frontiersin.org
The thyroid-stimulating hormone receptor (TSH-R) is predominantly expressed in the
basolateral membrane of thyrocytes, where it stimulates almost every aspect of their …

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

A Gulbins, M Horstmann, A Daser, U Flögel… - Frontiers in …, 2023 - frontiersin.org
Introduction Graves' disease (GD) is an autoimmune disorder caused by autoantibodies
against the thyroid stimulating hormone receptor (TSHR) leading to overstimulation of the …

Immunological aspects of Graves' ophthalmopathy

D Łacheta, P Miśkiewicz, A Głuszko… - BioMed research …, 2019 - Wiley Online Library
The body's autoimmune process is involved in the development of Graves' disease (GD),
which is manifested by an overactive thyroid gland. In some patients, autoreactive …

Immune mechanisms in thyroid eye disease

GM Lehmann, SE Feldon, TJ Smith, RP Phipps - Thyroid, 2008 - liebertpub.com
Thyroid eye disease (TED) is an inflammatory condition of the orbit closely associated with
Graves' disease. During the course of TED, fibrosis can develop around the extraocular …